Limitations of daclatasvir/asunaprevir plus beclabuvir treatment in cases of NS5A inhibitor treatment failure. [electronic resource]
Producer: 20190807Description: 1058-1065 p. digitalISSN:- 1465-2099
- Animals
- Antiviral Agents -- administration & dosage
- Benzazepines -- administration & dosage
- Biomarkers
- Carbamates
- Drug Combinations
- Drug Resistance, Viral
- Drug Therapy, Combination
- Genotype
- Hepacivirus -- drug effects
- Hepatitis C -- drug therapy
- Humans
- Imidazoles -- administration & dosage
- Indoles -- administration & dosage
- Isoquinolines -- administration & dosage
- Mice
- Protease Inhibitors -- administration & dosage
- Pyrrolidines
- Sulfonamides -- administration & dosage
- Treatment Failure
- Valine -- analogs & derivatives
- Viral Nonstructural Proteins -- antagonists & inhibitors
- Viremia
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.